Login

Creating, facilitating, and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

Custom icon
Early Dialogues

Custom icon
Submission & Methodology

Custom icon
Assessments

Custom icon
National Implementation

PTJA14 – Pretomanid FGK is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (XDR), or treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB).

By admin  /  April 2, 2020

OTCA24 revised final project plan now available

By admin  /  March 27, 2020
OTCA24 revised final project plan now available

EUnetHTA 2020 Assembly – Welcome Guide now available

By admin  /  March 25, 2020
EUnetHTA 2020 Assembly – Welcome Guide now available

EUnetHTA Response to COVID-19

By admin  /  March 24, 2020
EUnetHTA Response to COVID-19

PTJA09 – Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)

By admin  /  March 12, 2020
PTJA09 – Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)

Services

Assessments

Tools

Have Questions? Check our FAQ